Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies

CLR-225 for the Treatment of Solid TumorsFLORHAM PARK, N.J. and LANSING, Mich., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Cellectar ...

MellingMedical Joins Forces with Converge Medical Technology to Bring Innovative Spine Care Solutions to the Federal Healthcare System

MellingMedical today announced a strategic partnership with Converge Medical Technology, a leader in evidence-based solutions ...